Adooq Bioscience
Abiraterone (CB-7598) inhibits 17 ??-hydroxylase/C17,20 lyase (CYP17A1), an enzyme which is expressed in testicular, adrenal, and prostatic tumor tissues.
More Information
Supplier Page
Adooq Bioscience
ABT-263 (Navitoclax) is a potent orally bioavailable SMI that is structurally related to ABT-737. ABT-263 disrupts Bcl-2 – Bcl-XL interactions with pro-apoptotic proteins .
More Information
Supplier Page
ABT-263 25mg
25mg
| Purity Not Available
Adooq Bioscience
ABT-263 (Navitoclax) is a potent orally bioavailable SMI that is structurally related to ABT-737. ABT-263 disrupts Bcl-2 – Bcl-XL interactions with pro-apoptotic proteins .
More Information
Supplier Page
ABT-751 200mg
200mg
| Purity Not Available
Adooq Bioscience
ABT-751 is an antimitotic agent, inhibits microtubule polymerization, binds to β-tubulin on the colchine site; blocks cell cycle at G2M phase and induces apoptosis.
More Information
Supplier Page
Adooq Bioscience
ABT-751 is an antimitotic agent, inhibits microtubule polymerization, binds to β-tubulin on the colchine site; blocks cell cycle at G2M phase and induces apoptosis.
More Information
Supplier Page
ABT-751 100mg
100mg
| Purity Not Available
Adooq Bioscience
ABT-751 is an antimitotic agent, inhibits microtubule polymerization, binds to β-tubulin on the colchine site; blocks cell cycle at G2M phase and induces apoptosis.
More Information
Supplier Page
ABT-751 10mg
10mg
| Purity Not Available
Adooq Bioscience
ABT-751 is an antimitotic agent, inhibits microtubule polymerization, binds to β-tubulin on the colchine site; blocks cell cycle at G2M phase and induces apoptosis.
More Information
Supplier Page
ABT-492 50mg
50mg
| Purity Not Available
Adooq Bioscience
ABT-492 5mg
5mg
| Purity Not Available
Adooq Bioscience
ABT-492 100mg
100mg
| Purity Not Available
Adooq Bioscience